Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-08-22FDA Approved: AMPYRA — Supplemental Application (Merz Pharmaceuticals, LLC)
The FDA approved a supplemental application for AMPYRA (dalfampridine) from Merz Pharmaceuticals, LLC.
-
FDA approval · 2014-08-22FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod HCl) submitted by Novartis Pharmaceuticals Corporation. The action updat…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Betaferon® Regulatory Post-Marketing Surveillance
A completed regulatory post-marketing surveillance trial for Betaferon (interferon beta-1b) assessing safety in multiple sclerosis and clini…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers [Phase 1]
A Phase 1 study evaluating the pharmacokinetics of a single 14 mg teriflunomide tablet in healthy Chinese volunteers has completed.
-
FDA approval · 2014-08-18FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for Tecfidera (dimethyl fumarate), resulting in an approved modification to its labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-08-15FDA Approved: PLEGRIDY PEN — Original Application (Biogen Inc.)
The FDA approved Plegridy Pen (peginterferon beta-1a) from Biogen in an original application, making it a self-administered disease-modifyin…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.
A post-marketing surveillance study assessed the tolerability of Rebif's new formulation in relapsing multiple sclerosis patients in Austral…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Pregnancy Exposure Registry for Tysabri®
The Pregnancy Exposure Registry for natalizumab (Tysabri) has completed data collection, documenting outcomes in patients with Crohn's disea…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial (PRISMS-15)
A completed pharmacogenetic trial and long-term follow-up of the PRISMS trial in multiple sclerosis. The study was sponsored by Merck KGaA.
-
CLINICAL_TRIALS research · 2014-07-31Clinical Trial Update: A Retrospective Study to Understand the Clinical Management of Subjects With Multiple Sclerosis at a Site in Taiwan Over the Last 10 Years
A retrospective study examining how multiple sclerosis patients were clinically managed at a site in Taiwan over the last 10 years.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple Sclerosis
This completed clinical trial, sponsored by Merck KGaA, evaluated factors that predict depression in patients with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis
This clinical trial update notes the completed Rebif Compliance Support Program study assessing needs in people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Mobility Enhancing Nursing Intervention [NA]
This entry reports the completion status of a clinical trial evaluating a mobility-enhancing nursing intervention for stroke and multiple sc…
-
CLINICAL_TRIALS research · 2014-07-18Clinical Trial Update: Neuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation Program [NA]
The document reports on the neuropsychological profile of a group of people with multiple sclerosis and assesses the impact of a cognitive r…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy
This document reports results from a completed observational study comparing two quality-of-life instruments (MusiQoL and MSQOL-54) in relap…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis
An observational study evaluating the effectiveness and tolerability of Rebif 44 µg or 22 µg in chronic multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Evaluation of Brain Atrophy in CIS Patients on Avonex
A completed clinical trial evaluated brain atrophy in patients with clinically isolated syndrome who were treated with Avonex (interferon be…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis Subjects
This completed trial update reports on treatment adherence outcomes for relapsing multiple sclerosis patients using the RebiSmart autoinject…
-
CLINICAL_TRIALS other · 2014-07-08Clinical Trial Update: Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients [Phase 2]
Phase 2 trial of oral testosterone for fatigue in male multiple sclerosis patients was terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials. [Phase 3]
This is an open-label extension study in Canadian participants with multiple sclerosis evaluating safety and tolerability of oral dalfamprid…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Use of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic Tremor [NA]
An update on a clinical trial evaluating two deep brain stimulation electrodes to treat post-traumatic tremor, with results posted in 2014.
-
CLINICAL_TRIALS research · 2014-06-26Clinical Trial Update: Physical Disability in Patients Treated With Betaferon
A Bayer-sponsored clinical trial assessing physical disability in patients treated with Betaferon for Multiple Sclerosis has completed.
-
CLINICAL_TRIALS research · 2014-06-17Clinical Trial Update: A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment
This completed multi-center observational study evaluated whether the MusiQoL quality-of-life instrument responds to changes in EDSS status …
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Dalfampridine for Imbalance in Multiple Sclerosis [Phase 2]
Phase 2 trial results of dalfampridine (Ampyra) for imbalance in people with multiple sclerosis were posted in 2014. The study evaluated out…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study of the pegylated interferon beta-1a autoinjector (BIIB017) was conducted in healthy volunteers to assess its P…